DT120 clinical trials

A Phase 3 Trial of MM120 for Generalized Anxiety Disorder (Panorama)

This study is testing a new medicine called MM120 for people with Generalised Anxiety Disorder (GAD). It compares MM120 to a dummy pill (placebo) to see if it helps reduce anxiety. The study involves one dose of the medicine followed by a longer monitoring period.